908 Devices (MASS) Return on Capital Employed Growth (1y) (2022 - 2026)
908 Devices (MASS) Return on Capital Employed Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.69 Bn | 175.40 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | -1,390.00 |
| 3 | Medtronic | 108.07 Bn | 98.85 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 67.93 Bn | 66.47 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 48.11 Bn | 44.44 Bn | 1.29 Bn | -110.00 |
| 6 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn | 658.00 |
| 7 | GE HealthCare Technologies | 27.89 Bn | 25.60 Bn | 1.98 Bn | -3,185.00 |
| 8 | Smith & Nephew | 26.99 Bn | 26.42 Bn | - | - |
| 9 | Koninklijke Philips | 24.05 Bn | 20.92 Bn | 2.07 Bn | 125.00 |
| 10 | 908 Devices | 263.99 Mn | 152.25 Mn | 6.88 Mn | 1,069.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,069.00 |
| Dec 31, 2025 | 1,473.00 |
| Sep 30, 2025 | -955.00 |
| Jun 30, 2025 | -2,139.00 |
| Mar 31, 2025 | -1,734.00 |
| Dec 31, 2024 | -1,659.00 |
| Sep 30, 2024 | -685.00 |
| Jun 30, 2024 | 163.00 |
| Mar 31, 2024 | -274.00 |
| Dec 31, 2023 | -774.00 |
| Sep 30, 2023 | -1,068.00 |
| Jun 30, 2023 | -989.00 |
| Mar 31, 2023 | -772.00 |
| Dec 31, 2022 | -450.00 |
| Sep 30, 2022 | 215.00 |
| Jun 30, 2022 | 25.00 |
| Mar 31, 2022 | -530.00 |